Neuro65/AOCN2024

Session information

English Poster Session

English

[Pe-017] English Poster Session 017「Neurogenetics, Gene therapy, and iPS cell 1」

Wed. May 29, 2024 5:20 PM - 6:40 PM Poster (Hall E, E Block, B2F, TIF)

Chair(s): Chikako Nito (Laboratory for Clinical Research, Collaborative Research Center, Nippon Medical School, Japan), Hiroshi Doi (Department of Neurology and Stroke Medicine, Yokohama City University, Japan)

Monami Osawa1, Yuanzhe Li1, Hiroyo Yoshino2, Yuka Suganuma1, Manabu Funayama1,2, Nobutaka Hattori1,2,3 (1.Department of Neurology, Faculty of Medicine, Juntendo University, Japan, 2.Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Japan, Japan, 3.Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, Japan)

Manabu Funayama1,2,9, Kensuke Daida2,3,4, Billingsley Kimberley3, Malik Laksh4, Miano-burkhardt Abigail3, Leonard Hampton3,4,5,6, Makarious Mary3,7,8, Hirotaka Iwaki4,5, Ding Jinhui3, Gibbs Raphael3, Mayu Ishiguro2, Hiroyo Yoshino1, Kotaro Ogaki2, Genko Oyama2, Kenya Nishioka2, Risa Nonaka2,9, Wado Akamatsu9, Blauwendraat Cornelis3,4, Nobutaka Hattori1,2,9,10 (1.Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Japan, 2.Department of Neurology, Faculty of Medicine, Juntendo University, Japan, 3.Laboratory of Neurogenetics, NIA, NIH, USA, 4.Center for Alzheimer's and Related Dementias (CARD), NIA, NINDS, NIH, USA, 5.Data Tecnica International LLC, USA, 6.German Center for Neurodegenerative Diseases (DZNE), Germany, 7.Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, UK, 8.UCL Movement Disorders Centre, University College London, UK, 9.Center for Genomic and Regenerative Medicine, Graduate School of Medicine, Juntendo University, Japan, 10.Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, Japan, Japan)

Mayu Ishiguro1, Manabu Funayama1,2,3, Taku Hatano1, Hiroshi Nishida4, Yuko Wada5, Kazuyuki Noda6, Masahiko Tomiyama7, Hiroyo Yoshino2, Yuanzhe Li1,8, Ong Stephanie1,3, Cioffi Ettore1, Kenya Nishioka9, Nobutaka Hattori1,2,3,8,10 (1.Department of Neurology, Faculty of Medicine, Juntendo University, Japan, 2.Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Japan, 3.International Collaborative Research Administration, Juntendo University, Japan, 4.Department of Neurology, Gifu Prefectural General Medical Center, Japan, 5.Department of Neurology, Rakuwa-kai Otowa hospital, Japan, 6.Department of Neurology, Juntendo University Shizuoka Hospital, Japan, 7.Department of Neurology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Japan, 8.Department of Diagnosis, Prevention and Treatment of Dementia, Graduate School of Medicine, Juntendo University, Japan, 9.Department of Neurology, Juntendo Tokyo Koto Geriatric Medical Center, Japan, 10.Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, Japan)

Hidefumi Suzuki1,2,3, Naohiro Egawa1,2,3, Keiko Imamura2,3,4, Takayuki Kondo2,3,4, Kayoko Tsukita2,3, Ayako Nagahashi2,4, Takako Enami2,4, Kazuko Hasegawa5, Hirofumi Maruyama6, Hideyuki Sawada7, Tomoko Oeda7, Mitsuo Kodama8, Tsuyoshi Uchiyama9, Ryosuke Takahashi1, Haruhisa Inoue2,3,4 (1.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 2.Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, 3.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Japan, 4.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Japan, 5.Department of Neurology, National Hospital Organization Sagamihara National Hospital, Japan, 6.Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan, 7.Clinical Research Center and Department of Neurology National Hospital Organization Utano Hospital, Japan, 8.Department of Neurology, Koshokai Aobaoka Hospital, Japan, 9.Department of Neurology, Seirei Hamamatsu General Hospital, Japan)

Akihiko Mitsutake1,2, Rimi Hino1, Yuto Sakai2, Takashi Matsukawa1, Jun Mitsui3, Hiroyuki Ishiura1,4, Nobue K. Iwata2, Shoji Tsuji3,5, Tatsushi Toda1 (1.Department of Neurology, The University of Tokyo Hospital, Japan, 2.Department of Neurology, International University of Health and Welfare Mita Hospital, Japan, 3.Department of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, Japan, 4.Department of Neurology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan, 5.Institute of Medical Genomics, International University of Health and Welfare, Japan)

Ikuko Iwata1, Niino Masaaki2, Monami Tarisawa1, Hisashi Uwatoko1, Shinichi Shirai1, Masaaki Matsushima1, Hiroaki Yaguchi1, Ganpei Nakahara3, Satoko Miyatake4,5, Naomichi Matsumoto4, Ichiro Yabe1 (1.Department of Neurology, Hokkaido University, Japan, 2.Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Japan, 3.Department of Neurology, Nakamura Memorial Hospital, Japan, 4.Department of Human Genetics, Yokohama City University Graduate School of Medicine, Japan, 5.Department of Clinical Genetics, Yokohama City University Hospital, Japan)